Serena Calamaio - Publications

Exploring light chain cardiotoxicity in AL amyloidosis: impact on hiPSC-derived cardiomyocyte activity.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: June 19, 2026

Integrated electrophysiological, cellular, and pharmacological profiling reveals variant-specific mechanisms in SCN4A-related myotonia.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 07, 2026

Functional reassessment of Nav1.5 T559A reveals loss-of-function in a variant commonly used as wild type.

Journal: American journal of physiology. Cell physiology

Published: July 11, 2025

NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications.

Journal: European heart journal

Published: December 19, 2023

Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights.

Journal: International journal of molecular sciences

Published: September 08, 2023

A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic diet.

Journal: Epilepsia

Published: July 13, 2023

Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System.

Journal: Biomedicines

Published: June 22, 2023

Automated Patch-Clamp and Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Synergistic Approach in the Study of Brugada Syndrome.

Journal: International journal of molecular sciences

Published: February 20, 2023

T-Type Calcium Channels: A Mixed Blessing.

Journal: International journal of molecular sciences

Published: August 03, 2022

Generation of the induced pluripotent stem cell line UNIBSi017-A from an individual with cardiospondylocarpofacial syndrome and the MAP3K7 c.737-7A > G variant.

Journal: Stem cell research

Published: May 11, 2022